Integral Privacy Technologies ads

Most pharma companies are spending 12+ weeks working with consultants just to get a dataset HIPAA-compliant. And here's what's happening: they take the entire dataset and apply the strictest possible de-identification across the board - way more than what's actually needed for most use cases. Your marketing team doesn't need the same level of restrictions as your clinical research team. Your analytics work could be far more valuable with more granular data. But you've already committed to this one-size-fits-all approach, so now you're stuck. What happens next? Either you've stripped out so much data that it's barely useful, or you're cycling back through the same certification process over and over for different teams and use cases. Both scenarios mean you're burning months while your data becomes stale. Integral has solved this with a different-in-kind approach. We enable teams to work with the same source data but create fit-for-purpose datasets - each one certified with exactly the right privacy controls for its specific use case. The difference is we're applying the appropriate level of protection for what that data is actually being used for. We had a Top 5 pharma customer go from 6-month certification timelines to activating data in a week. They didn't lower the bar on protecting patient privacy - they just stopped over-engineering protections while enabling compliance everywhere. If your organization is constantly trading off between data utility and compliance speed, that's a signal that your infrastructure isn't built for how teams actually need to work with regulated data today. We can help with that. useintegral.com

The next revolution is here: AI is already transforming the multi-billion healthcare sector, from drug distribution to R&D and real-time care. But its progress depends on the quality and accuracy of the data beneath it. We’re excited to announce Integral 2.0, a compliant data platform that unlocks real-time access to multimodal health data. Enterprises are eager to harness rich, multimodal datasets including images, text, audio, PDFs, and more to capture every dimension of human health. But they lacked the right infrastructure - until now. We’re already working with some of the largest companies in the world, and we’re just getting started.

Imagine you could only test drive a car after you bought it. That's how most companies evaluate health data purchases today. They commit to partnerships, sign procurement contracts, hire staff - all before really understanding what's usable, how the dataset will be transformed due to compliance, or whether the dataset will even work for their use case. So what happens? Pharma companies are stuck passing on potentially valuable Real World Evidence because they can't justify the risk. Health tech teams avoid external datasets entirely. Data providers struggle to demonstrate value upfront. Everyone plays it safe, and innovation grinds to a halt. The problem isn't the data. It's the inability to kick the tires before committing. At Integral Privacy Technologies, we're building the tools that let data teams actually evaluate datasets before purchase - understanding privacy risks, remediation options, and utility tradeoffs upfront. It's about moving from "we probably can't use this" to "here's exactly what we can do with it." Proud to be powering privacy-compliant data workflows with our partners. PurpleLab, LiveRamp, Skyflow, Datavant, AnalyticsIQ

Really enjoyed my conversation with David E. Williams on the CareTalk Podcast: Healthcare. Unfiltered. about what we've built at Integral. David asked some tough questions about why so much healthcare data sits unused - and he's right, it's been frustrating for years watching valuable data get stuck in compliance bottlenecks while innovators are forced to choose between speed and regulation. We talked about how we're collapsing the data stack and compliance stack into one. It's almost like using a scalpel versus a hatchet - you can be precise about what you need while still reducing risk. One top pharma customer went from activating 2-3 datasets a year (at 8-12 weeks each) to deploying monthly. That's real ROI they can (and do) take to their QBRs. We love to hear it when data scientists tell us they can finally iterate at the speed they need to. They're not playing compliance analyst anymore - they're doing what they do best. And ultimately, that means better distribution strategies, more targeted awareness campaigns, and people with rare diseases actually finding out about treatments that could help them. Thanks David E. Williams, John Driscoll for the conversation and for highlighting the opportunity to make healthcare data actually usable. https://lnkd.in/e986TAzy #HealthcareData #DataInfrastructure #HIPAA

AI companies are paying millions for company data. 🔒 Keep the training signal buyers want while protecting your company and your customers. Retain signal. Stay protected. Get paid. https://lnkd.in/eaXZYPAQ

Data de-identification is becoming core infrastructure for the training data economy. As more private proprietary data from real individuals and companies enters AI, de-identification becomes the trust layer that gives data owners confidence to release it. Most solutions still force you to adapt to them. We built our new API to work the other way around. Deploy in the cloud, your VPC, or on-prem. Drop it into an existing pipeline. Configure what it detects, removes, and transforms. That means you can: → License training data against specific privacy requirements → Fine-tune internally without exposing PHI or PII → Support new data partnerships without rebuilding your privacy stack One de-identification layer, configurable to the data, policy, and environment, with fit for purpose regulatory-grade documentation when needed. We’re opening early access ahead of general availability 🚀🚀🚀🚀🚀 Request access: bleach.useintegral.com